Mitchell Eric Horwitz
Professor of MedicineOverview
Allogeneic stem cell transplantation with a focus on the use of umbilical cord blood grafts; Allogenic stem cell transplantation for Sickle Cell Disease; Prevention of acute and chronic graft versus host disease; Improving immune recovery following alternative donor stem cell transplantation using donor graft manipulation.
Positions
Professor of Medicine in the School of Medicine
2016 School of Medicine
Affiliate of the Duke Regeneration Center in the School of Medicine
2021 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
2003 School of Medicine
Education
M.D., Rush University 1992
1992 Rush University
Medical Resident, Northwestern University, Medicine 1992 - 1995
1995 Northwestern University
Clinical Trials
Publications, Grants & Awards
- Grants (26)
- Academics Articles (141)
- Conference Pages (59)
- Book Sections (1)
Showing 1 - 5 of 26
Blood and Marrow Transplant Clinical Trials Network
National Institutes of Health
A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Haploidentical Related, Partially HLA-Mismatched, or Matched Unrelated Bone Marrow for Newly Diagnosed Patients with Severe Aplastic Anemia
National Marrow Donor Program
A randomized, open-label study evaluating the efficacy and safety of cemacabtagene
ansegedleucel in participants with minimal residual disease after response to first
line therapy for large B-cell lymphoma (ALPHA3)
Allogene Therapeutics, Inc.
A Phase 3, Randomized, Open-Label, Multicenter Study, to Compare T-Guard to Ruxolitinib for the Treatment of Patients with Grade III or IV Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD) BMT CTN Protocol #2002
National Marrow Donor Program
Hematology & Transfusion Medicine (T32)
National Institutes of Health
DCI Centers, Cancer Types & Labs
Offices & Contact
2400 Pratt St Suite 5000
Durham, NC
27710
2400 Pratt St Suite 5000
Durham, NC
27710